Details for Patent: 9,937,075

✉ Email this page to a colleague

Which drugs does patent 9,937,075 protect, and when does it expire?

Patent 9,937,075 protects XIPERE and is included in one NDA.

This patent has twenty-eight patent family members in thirteen countries.

Summary for Patent: 9,937,075

Title:	Apparatus and methods for ocular injection
Abstract:	An apparatus includes a housing coupled to a medicament container, which is coupled to a needle. An injection assembly is disposed within the housing and includes an energy storage member and an actuation rod. A distal end portion of the actuation rod is disposed within the medicament container. The energy storage member can produce a force on a proximal end portion of the actuation rod sufficient to move the distal end portion of the actuation rod within the medicament container. This can convey at least a portion of a substance from the medicament container via the needle when a distal tip of the needle is disposed within a first region of a target location. The force is insufficient to move the distal end portion of the actuation rod within the medicament container when the distal tip of the needle is disposed within a second region of the target location.
Inventor(s):	Andino; Rafael Victor (Grayson, GA), Zarnitsyn; Vladimir (Atlanta, GA), Yoo; Jesse (Snellville, GA), Brooks; Christopher John (Glen Cove, NY), Kahute; Trent John (Atlanta, GA), Arsenault; Justin William (Atlanta, GA), Trettin; David Jackson (Atlanta, GA), Bauer; Andrew Kent (Atlanta, GA), Lewis; Stephanie Elaine (Atlanta, GA)
Assignee:	CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA)
Application Number:	15/714,441
Patent Claim Types: see list of patent claims	Device; Dosage form;

Drugs Protected by US Patent 9,937,075

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bausch And Lomb Inc	XIPERE	triamcinolone acetonide	SUSPENSION;INJECTION	211950-001	Oct 22, 2021		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,937,075

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014259694	⤷ Sign Up
Brazil	112015027762	⤷ Sign Up
Canada	2911290	⤷ Sign Up
Canada	3121759	⤷ Sign Up
China	105246529	⤷ Sign Up
China	110302004	⤷ Sign Up
China	116327482	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.